| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9356 |
| Human Intestinal Absorption | HIA+ | 0.9929 |
| Caco-2 Permeability | Caco2+ | 0.6431 |
| P-glycoprotein Substrate | Non-substrate | 0.8687 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9021 |
| Non-inhibitor | 0.9264 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8526 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5976 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7402 |
| CYP450 2D6 Substrate | Non-substrate | 0.9117 |
| CYP450 3A4 Substrate | Non-substrate | 0.7559 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9473 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9175 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9471 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9567 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9065 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8301 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9294 |
| Non-inhibitor | 0.8700 |
| AMES Toxicity | Non AMES toxic | 0.9185 |
| Carcinogens | Non-carcinogens | 0.9333 |
| Fish Toxicity | Low FHMT | 0.8045 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5579 |
| Honey Bee Toxicity | Low HBT | 0.8506 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.7736 |
| Carcinogenicity (Three-class) | Non-required | 0.4912 |